Neoadjuvant intravenous cisplatin for T2-4NxMo bladder cancer.
Raghavan
D
D
Royal Prince Alfred Hospital, Sydney, Australia.
Pearson
B
B
Duval
P
P
Rogers
J
J
Watt
H
H
Tynan
A
A
D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000401:mortality / Q000628:therapy; D002945:Cisplatin / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D011879:Radiotherapy Dosage; D001743:Urinary Bladder / Q000601:surgery; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000628:therapy
D002945:Cisplatin